Gene Query: FAM219A

Dataset Description Geneva Score
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 37.48
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 36.15
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 32.07
Tracking of dCas9-methyltransferase footprints 25.03
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 24.68
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 24.26
SUV420H2 knockdown in PANC-1 23.64
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 23.47
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 23.15
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 22.61
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 22.61
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 22.35
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 22.04
RNA-seq of naive and primed ES cells (NHSM) 21.7
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 21.62
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 21.51
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 20.69
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 20.24
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 19.82
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 19.22
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 19.17
Effect of mitochondria deficiency on senescence-associated gene expression 18.69
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 18.02
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 18.02
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 17.81
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 16.94
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 16.94
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 16.8
Epigenomic landscape during organ formation in human early embryos 16.23
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 16.22
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 15.19
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 14.96
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 14.6
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 14.45
Gene expression changes after LOC550643 silencing 14.12
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 14.05
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 13.94
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 13.91
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 13.85
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 13.85
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 13.14
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 13.06
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 12.71
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 12.68
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 12.27
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 12.22
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 12.12
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 11.94
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 11.76
UBC9 knockdown in bladder cancer T24 cell lines 11.75
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 11.71
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 11.54
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 11.54
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 11.52
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 11.52
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 11.43
Total RNA sequencing of APC mutant and wt colonic organoids 11.41
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 11.35
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.34
Examining serotonergic neuron differentiation from human iPSCs 11.3
Differentially expressed vascular development genes for iPSC-ECs from CDI 11.25
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 11.23
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 11.18
Total RNA sequencing of WT intestinal orgaonids. 11.06
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 10.7
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 10.67
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 10.59
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 10.42
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 10.42
Altering cancer transcriptomes using epigenomic inhibitors 10.42
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 10.42
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 10.25
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 10.25
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 10.23
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 10.14
Effect of disulfiram treatment on pediatric high grade glioma 10.04
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 10.01
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.92
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 9.73
Aneuploidy-induced cellular stresses limit autophagic degradation. 9.63
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 9.56
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 9.14
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 9.14
Ebola virus (EBOV) infection of ARPE-19 cells 9.06
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.04
circRNA-sequencing 9.0
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 8.95
Statins modulate endothelial transcriptional profile by inhibiting EZH2 8.89
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 8.85
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 8.65
AUF-1 affected genes in human skin cells 8.64
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 8.55
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 8.52
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 8.52
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 8.51
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 8.5
RNA splicing alteration on glioblastoma and normal neural stem cells 8.45
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 8.44
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 8.43
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.4
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 8.29
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 8.28
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 8.23
Small-molecule targeting of brachyury transcription factor addiction in chordoma 8.13
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 8.1
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 8.08
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 8.04
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.04
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 8.02
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 8.0
Genetic-to-epigenetic Therapy for Pancreatic Cancer 7.91
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 7.67
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 7.63
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 7.59
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 7.59
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 7.56
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 7.42
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.41
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.32
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.27
An integrative analysis of non-coding regulatory DNA variations associated with autism 7.27
RNA expression following TMPRSS11B overexpression or depletion 7.25
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 7.23
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 7.2
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.19
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 7.1
Generation of KRAS signatures using immortalized isogenic lung cells. 7.07
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.07
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 7.0
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 6.89
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 6.85
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 6.81
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 6.8
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 6.78
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.78
Silencing p300 in MCF7 cells to study expression and alternative splicing 6.72
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 6.72
RNA sequencing analysis of human embryonic stem cells and axial progenitors 6.69
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 6.69
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 6.54
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 6.51
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 6.5
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 6.5
FGF2 regulation of gene expression in stable inducible Neurons 6.43
Disruption of GRIN2B impairs differentiation in human neurons 6.38
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 6.37
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 6.33
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 6.3
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 6.26
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 6.24
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 6.12
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 6.11
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 6.1
The human blood-nerve barrier transcriptome 6.06
The effect of PPARG inhibition on human angiomyolipoma cells 6.06
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.05
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 6.05
Differential expression of genes in AD169-infected MRC5. 6.04
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 5.93
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 5.92
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.91
Dtx3L and Androgen Signaling in Prostate Cancer 5.87
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 5.87
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 5.87
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 5.86
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.86
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 5.83
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 5.81
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 5.8
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 5.8
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 5.79
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 5.78
High level DNA repair gene expression in human ES cells 5.78
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 5.77
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 5.73
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.72
Gene expression in PANC1 cells treated with Rakicidin 5.7
Dissecting neural differentiation regulatory networks through epigenetic footprinting 5.67
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.66
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 5.59
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 5.57
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 5.57
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.55
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 5.55
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 5.48
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 5.47
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.46
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.46
Transcriptional responses of human insulinoma cells to acute cytokine exposure 5.45
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 5.44
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 5.41
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.4
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 5.4
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 5.37
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 5.37
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 5.35
Control of prostate tumour growth by the long non-coding RNA GHSROS 5.26
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 5.23
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 5.21
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.19
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 5.18
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 5.18
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 5.14
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 5.14
Effect of nuclear IL-33 on gene expression 5.11
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 5.11
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 5.05
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 5.04
The age and genomic integrity of neurons after cortical stroke in humans 5.0
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 4.97
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.94
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 4.92
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 4.9
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.89
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 4.85
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.83
Engineering Patient-Specific Tissue Implants 4.81
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 4.78
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 4.71
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 4.7
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 4.7
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 4.68
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.65
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 4.63
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.62
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.58
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.5
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.49
RNA-seq analysis to identify the genes regulated by p53-SET interplay 4.46
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.44
Universal alternative splicing of noncoding exons 4.42
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.38
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 4.35
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 4.34
Global transcriptome analysis of HAP1 cells 4.34
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 4.33
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 4.3
Genome-wide functional assessment of enhancer activities in the human genome 4.29
RNA transcriptome analysis during HSV-1 infection 4.28
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.27
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.27
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 4.27
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 4.23
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.19
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 4.19
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 4.19
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 4.19
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 4.18
Analysis of transcriptional regulation by Myt1 and Myt1l 4.15
Effect of PRDM11 depletion in U2932 cells 4.11
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 4.08
Rorc disruption in human FG pancreatic cancer cells 4.08
CSL RNA-Seq on HKC and SCC cell lines 4.06
CSL 4.06
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 4.04
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.02
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 4.02
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 4.02
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.0
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.0
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.0
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 3.95
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 3.95
Gene expression regulated by CSA and CSB in neuroblastoma cell line 3.95
RNA-seq in transgenic cells 3.95
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 3.85
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 3.84
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.82
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.82
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 3.82
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.79
ENCODE Cold Spring Harbor Labs Long RNA-seq 3.73
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.72
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.72
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 3.71
High-throughput sequencing of pluripotent cells 3.71
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 3.69
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.67
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.67
Global response to chemotherapy-induced apoptosis 3.66
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 3.65
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 3.65
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 3.64
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 3.64
Global analysis of alternative splicing regulated by RBM10 3.63
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 3.62
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.61
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.6
Hepatitis C virus functionally sequesters miR-122 3.59
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.59
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 3.54
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.52
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 3.5
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 3.5
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 3.48
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.47
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 3.46
Energy Metabolism during Anchorage-Independence 3.45
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.44
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 3.43
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 3.4
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.34
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 3.33
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 3.24
Repurposing of promoters and enhancers during mammalian evolution 3.23
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 3.17
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 3.12
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 3.11
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.1
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.09
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 3.05
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.04
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.0
Exploring ILF2 regulatory genes by next-generation sequencing 2.99
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 2.98
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.98
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.98
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 2.96
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 2.96
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 2.96
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.96
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.93
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 2.93
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 2.93
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.92
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 2.91
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.91
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.91
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.81
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 2.74
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.7
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.68
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.67
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 2.66
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.63
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.63
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.62
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 2.6
Studying the selectivity of a small molecule Synucleozid on transcriptome 2.58
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.55
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.53
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.52
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 2.51
NKX2.2 2.51
Investigate A2M treatment on human prostate cancer and mouse liver 2.48
Investigate A2M treatment on human prostate cancer xenograft in mice 2.48
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 2.46
Zika virus directly infects human peripheral neurons and induces cell death 2.44
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 2.42
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 2.4
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.39
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 2.34
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 2.34
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.33
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.33
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.33
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 2.32
RNA sequencing of human mammary epithelial cells 2.32
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.32
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.32
Gene expression analysis upon mtDNA depletion 2.31
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.31
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.31
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 2.28
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.27
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.24
RNA-Seq in PWS iPSC-derived neurons 2.22
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.21
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.21
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.2
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.19
Role of FGFR1 in neuronal devlopment 2.18
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.17
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 2.15
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 2.15
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 2.1
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 2.1
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 2.06
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.04
Gene expression in GBM with Cav3.2 inhibition 2.03
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.96
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.96
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 1.95
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.95
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.93
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.92
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.92
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.91
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.91
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.91
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.91
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.91
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.91
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.9
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.9
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 1.89
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.88
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.87
miR941 overexpression experiment 1.84
X-Ray induced DNA-Hydroxymethylation changes 1.78
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.74
RNA-seq analysis upon ARID1B overexpression 1.73
CD73 knockdown effect in pancreatic cancer cell lines 1.68
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.64
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.59
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.56
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.51
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.5
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.46
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.46
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.44
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.44
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 1.42
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 1.38
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.35
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.32
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.31
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.31
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.3
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.27
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 1.24
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.23
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.23
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 1.22
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.21
Determining mRNA half-lives on a transcriptome-wide scale 1.18
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.15
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.15
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.15
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.1
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 1.07
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.03
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.03
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.02
Finding missing proteins from epigenetically manipulated human cells 0.99
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.96
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.94
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.93
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.92
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.9
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.88
Discovering human diabetes-risk gene function with genetics and physiological assays 0.88
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.83
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.79
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 0.78
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 0.78
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.76
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.74
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.69
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.62
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.59
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.57
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.57
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.56
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.52
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.52
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.52
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.51
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.49
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 0.49
Nucleoporin-mediated regulation of cell identity genes 0.48
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.46
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.45
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.45
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.44
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.39
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.39
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.39
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.38
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.37
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.35
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.34
STX4 Over-Expression in Human islets 0.34
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.32
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.28
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.26
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.26
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.26
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.25
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.23
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.23
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.23
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.23
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.18
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.15
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.13
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.12
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.11
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.09
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.09
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.09
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 0.09
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.08
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.06
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.05
Function and hormonal regulation of GATA3 in human first trimester placentation 0.02
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.01
hESC neural differentiation 0.01
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.01
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation